![](/images/graphics-bg.png)
Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis
Joint Authors
Shang, Xiuling
Gong, Shurong
Yu, Rongguo
Jiang, Ying
Li, Jun
Zhang, Yingrui
Hu, Xinlan
Zhang, Xiaoguang
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-02-06
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Background.
Urosepsis and septic shock are a critical situation leading to a mortality rate up to 30% in patients with obstructive diseases of the urinary tract.
Aim.
To analyze the bacterial distribution and drug resistance of pathogenic bacteria in patients with urosepsis and to provide a basis for the rational application of antibacterial drugs in clinical practice.
Methods.
A retrospective analysis of 94 hospitalized patients with urosepsis for 6 years was performed.
The strain composition, resistance characteristics, and the antibiogram of common bacteria from positive blood and midstream urine culture were analyzed.
Results.
A total of 87 strains were isolated, including 65 strains (74.71%) of Gram-negative bacilli, 14 strains (16.09%) of Gram-positive cocci, and 8 strains (9.20%) of fungi.
The Gram-negative bacilli included 42 strains of Escherichia coli (E.
coli) (64.62%), among which 34 strains (80.95%) were producing ESBLs, and 14 strains (21.84%) of Klebsiella pneumoniae (K.
pneumoniae), among which nine strains (64.29%) were producing ESBLs.
The most common pathogenic bacteria, ESBL+ E.
coli and K.
pneumoniae strains, showed sensitivity towards imipenem, ertapenem, piperacillin/tazobactam, amikacin, and cefotetan, but were highly resistant to quinolones.
The cure rate of urosepsis was 88.30%, and the susceptibility rate of septic shock was 45.47%.
Significance.
Gram-negative bacterial infections are the main cause of urosepsis.
The mild patient group showed more E.
coli (ESBL-) infections, and the number of ESBL producing E.
coli isolated from the mild group showed higher drug resistance rates for aztreonam and levofloxacin compared with isolates from the severe group.
American Psychological Association (APA)
Jiang, Ying& Li, Jun& Zhang, Yingrui& Hu, Xinlan& Zhang, Xiaoguang& Shang, Xiuling…[et al.]. 2019. Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis. BioMed Research International،Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1124310
Modern Language Association (MLA)
Jiang, Ying…[et al.]. Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis. BioMed Research International No. 2019 (2019), pp.1-9.
https://search.emarefa.net/detail/BIM-1124310
American Medical Association (AMA)
Jiang, Ying& Li, Jun& Zhang, Yingrui& Hu, Xinlan& Zhang, Xiaoguang& Shang, Xiuling…[et al.]. Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1124310
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1124310